Health ❯ Healthcare ❯ Clinical Trials

Drug Development

Eli Lilly Combination Therapy Phase 3 Trials Targeted Therapy Alzheimer's Treatments Phase III Trials Patient Outcomes Oral Medications Antibody-Drug Conjugates FDA Approval

KRAS Pill Doubles Survival in Trial as Pancreatic Cancer Vaccine Advances

The early wins hint at a turn toward precision tools in a cancer with few options.

FDA Clears Dupixent as First Biologic for Young Children With Chronic Spontaneous Urticaria

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

Zoldonrasib Shows Promising Early Efficacy in KRAS G12D Lung Cancer

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

New Study Explains Why BET Drugs Falter by Splitting BRD2 and BRD4 Roles

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

NEJM Publication Confirms Phase 3 Win for Brepocitinib in Dermatomyositis

Autolus Reports Q4 Loss, Reaffirms 2026 Sales Outlook for AUCATZYL, and Starts AUTO8 Trial

Upstream Bio Sets Phase 3 Start for Verekitug in Severe Asthma and Nasal Polyps

RTW Buys $116 Million of Cogent Biosciences as Kynam Trims $48 Million Stake

Viking Therapeutics Pushes VK2735 Through Pivotal Trials as Next Enrollment Milestone Nears

Brazil Moves to Bolster IP After Polylaminin Patent Lapse as First Safety Trial Nears

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Priovant’s Brepocitinib Posts Strong Phase 2 Win in Cutaneous Sarcoidosis

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Triple-Drug Strategy Wipes Out Pancreatic Tumors in Mice, Study Finds